[
  {
    "ts": null,
    "headline": "Johnson And Johnson Faces Legal Risks While Cardiac Data Supports Valuation",
    "summary": "Pennsylvania jury awards damages in a talc lawsuit involving Johnson & Johnson products. Researchers identify a mechanism behind rare blood clots associated with the company’s COVID vaccine. Johnson & Johnson reports positive pilot phase safety and effectiveness data for its OMNYPULSE and VARIPULSE catheter platforms. Johnson & Johnson (NYSE: JNJ) sits at the center of several high impact developments that span litigation, vaccine safety research, and new medical device data. The stock last...",
    "url": "https://finnhub.io/api/news?id=28eb15d8bb30db71fa862377f586cdebb146e1dc887253433c839d52f0ce2850",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771024227,
      "headline": "Johnson And Johnson Faces Legal Risks While Cardiac Data Supports Valuation",
      "id": 139091174,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Pennsylvania jury awards damages in a talc lawsuit involving Johnson & Johnson products. Researchers identify a mechanism behind rare blood clots associated with the company’s COVID vaccine. Johnson & Johnson reports positive pilot phase safety and effectiveness data for its OMNYPULSE and VARIPULSE catheter platforms. Johnson & Johnson (NYSE: JNJ) sits at the center of several high impact developments that span litigation, vaccine safety research, and new medical device data. The stock last...",
      "url": "https://finnhub.io/api/news?id=28eb15d8bb30db71fa862377f586cdebb146e1dc887253433c839d52f0ce2850"
    }
  },
  {
    "ts": null,
    "headline": "Pennsylvania jury finds Johnson & Johnson liable for cancer in latest talc trial",
    "summary": "By Diana Novak Jones Feb 13 (Reuters) - A jury in Pennsylvania state court on Friday awarded $250,000 to the family of a woman who sued Johnson & Johnson alleging its talc-based baby powder was to",
    "url": "https://finnhub.io/api/news?id=cc3d15c54f320f48275aa2ba864e4193337c48baf83e6b93f0f26dd3ceb01904",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771012122,
      "headline": "Pennsylvania jury finds Johnson & Johnson liable for cancer in latest talc trial",
      "id": 139088029,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "By Diana Novak Jones Feb 13 (Reuters) - A jury in Pennsylvania state court on Friday awarded $250,000 to the family of a woman who sued Johnson & Johnson alleging its talc-based baby powder was to",
      "url": "https://finnhub.io/api/news?id=cc3d15c54f320f48275aa2ba864e4193337c48baf83e6b93f0f26dd3ceb01904"
    }
  },
  {
    "ts": null,
    "headline": "Pennsylvania Jury Finds Johnson & Johnson Liable For Woman's Ovarian Cancer - Attorney For National Talc Plaintiffs",
    "summary": "-Reuters",
    "url": "https://finnhub.io/api/news?id=042c5d7811f46e4fe7a996d0e4e187441d35590ba1bfde1cf7b4ab62b44bd6c0",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770997464,
      "headline": "Pennsylvania Jury Finds Johnson & Johnson Liable For Woman's Ovarian Cancer - Attorney For National Talc Plaintiffs",
      "id": 139096833,
      "image": "",
      "related": "JNJ",
      "source": "Benzinga",
      "summary": "-Reuters ",
      "url": "https://finnhub.io/api/news?id=042c5d7811f46e4fe7a996d0e4e187441d35590ba1bfde1cf7b4ab62b44bd6c0"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson (JNJ) Reports 100% Success in OMNY-AF Study",
    "summary": "Johnson & Johnson (NYSE:JNJ) is among the most profitable mega cap stocks to buy. On February 6, Johnson & Johnson (NYSE:JNJ) disclosed 12-month pilot-phase data from the OMNY-AF study, which examined the investigational OMNYPULSE Platform for the treatment of symptomatic paroxysmal atrial fibrillation (AFib). Announced during the 31st Annual AF Symposium in Boston, the results […]",
    "url": "https://finnhub.io/api/news?id=e058bcdd1d371f351458c43b2f8d5dd771596bd2c943dd83840b83450613ea92",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770995378,
      "headline": "Johnson & Johnson (JNJ) Reports 100% Success in OMNY-AF Study",
      "id": 139084998,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is among the most profitable mega cap stocks to buy. On February 6, Johnson & Johnson (NYSE:JNJ) disclosed 12-month pilot-phase data from the OMNY-AF study, which examined the investigational OMNYPULSE Platform for the treatment of symptomatic paroxysmal atrial fibrillation (AFib). Announced during the 31st Annual AF Symposium in Boston, the results […]",
      "url": "https://finnhub.io/api/news?id=e058bcdd1d371f351458c43b2f8d5dd771596bd2c943dd83840b83450613ea92"
    }
  },
  {
    "ts": null,
    "headline": "Why is Johnson & Johnson (JNJ) One of the Best Medical Research Stocks to Buy According to Hedge Funds?",
    "summary": "Johnson & Johnson (NYSE:JNJ) is one of the best medical research stocks to buy according to hedge funds. Johnson & Johnson (NYSE:JNJ) announced 12-month pilot-phase data from the OMNY-AF study on February 6 at the 31st Annual AF Symposium in Boston, evaluating the investigational OMNYPULSE Platform for the treatment of symptomatic paroxysmal atrial fibrillation. It […]",
    "url": "https://finnhub.io/api/news?id=d98498641309298fdabee2e0ec2a47b3ebe0449f7e5c1630c14f009a65c9621c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770994650,
      "headline": "Why is Johnson & Johnson (JNJ) One of the Best Medical Research Stocks to Buy According to Hedge Funds?",
      "id": 139084999,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Johnson & Johnson (NYSE:JNJ) is one of the best medical research stocks to buy according to hedge funds. Johnson & Johnson (NYSE:JNJ) announced 12-month pilot-phase data from the OMNY-AF study on February 6 at the 31st Annual AF Symposium in Boston, evaluating the investigational OMNYPULSE Platform for the treatment of symptomatic paroxysmal atrial fibrillation. It […]",
      "url": "https://finnhub.io/api/news?id=d98498641309298fdabee2e0ec2a47b3ebe0449f7e5c1630c14f009a65c9621c"
    }
  },
  {
    "ts": null,
    "headline": "H.C. Wainwright Bullish on ​Genmab A/S (GMAB) on Robust Sales for DARZALEX",
    "summary": "​Genmab A/S (NASDAQ:GMAB) is one of the High Growth International Stocks to Buy Now. On January 28, H.C. Wainwright reiterated a Buy rating on Genmab A/S (NASDAQ:GMAB) and maintained a $39 price target. The rating follows robust net sales of DARZALEX in 2025. ​The company on January 21 reported a significant increase in net sales […]",
    "url": "https://finnhub.io/api/news?id=b76213393f08e6507289a9f71c590ba1aa5bf7e705dd37e77e1e43e7abd6abda",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770977993,
      "headline": "H.C. Wainwright Bullish on ​Genmab A/S (GMAB) on Robust Sales for DARZALEX",
      "id": 139079721,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "​Genmab A/S (NASDAQ:GMAB) is one of the High Growth International Stocks to Buy Now. On January 28, H.C. Wainwright reiterated a Buy rating on Genmab A/S (NASDAQ:GMAB) and maintained a $39 price target. The rating follows robust net sales of DARZALEX in 2025. ​The company on January 21 reported a significant increase in net sales […]",
      "url": "https://finnhub.io/api/news?id=b76213393f08e6507289a9f71c590ba1aa5bf7e705dd37e77e1e43e7abd6abda"
    }
  }
]